Citropin-c

General Information


DRACP ID  DRACP02395

Peptide Name   Citropin-c

Sequence  GLFAVIHHVASVIGGL

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=156 ± 7 μM(pH=7.4); IC50=36 ± 2 μM(pH=5.5) MTT assay 2 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  CHO: IC50>120 μM(pH=7.4); IC50>120 μM(pH=5.5)

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02395

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C75H120N20O18

Absent amino acids  CDEKMNPQRTWY

Common amino acids  GV

Mass  185766

Pl  7.72

Basic residues  2

Acidic residues  0

Hydrophobic residues  10

Net charge  2

Boman Index  2850

Hydrophobicity  170

Aliphatic Index  164.38

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19464332

Title  Constructing bioactive peptides with pH-dependent activities

Doi 10.1016/j.peptides.2009.05.009

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_4534

DRACP is developed by Dr.Zheng's team.